Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nanoencapsulated Cannabidiol Time Released Capsules Targeted to Reduce Cravings in the Treatment of Opioid Addiction

NCT03813095 is registered in ClinicalTrials.gov with Aphios as lead sponsor.

NCT NCT03813095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03813095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nanoencapsulated Cannabidiol Time Released Capsules Targeted to Reduce Cravings in the Treatment of Opioid Addiction
Lead sponsor
Aphios
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2023
Completion date
December 31, 2025
Enrollment
32 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

addiction, opioid dependence, opioid withdrawal